Major clinical features of 3 patients with immunodeficiency and immune dysregulation
| . | P1 . | P2 . | P3 . |
|---|---|---|---|
| Immunodeficiency | |||
| Recurrent respiratory tract infections | ++ | + | ++ |
| Bronchiectasis | ++ | + | ++ |
| Herpes viral infection | ++ | + | + |
| Lymphoproliferation | |||
| Lymphadenopathy | + | + | + |
| Hepatosplenomegaly | + | + | + |
| Lymphoma | + | + | + |
| Autoimmunity | |||
| Autoimmune cytopenias | + | + | − |
| Autoantibodies | + | + | − |
| Laboratory values | |||
| Class-switched memory B cells | ↓ | ↓ | ↓ |
| FasL-mediated apoptosis | ↓ | ↓ | Normal |
| Soluble FasL | ↑ | ↑ | Normal |
| DNTs | ↑ | ↑/Normal | ↑ |
| Specific antibodies | Normal | ND | ↓ |
| Developmental delay | |||
| Moderate | + | + | + |
| Outcome of HSCT | |||
| Autologous T-cell reconstitution | + | + | + |
| Split mixed chimerism | Rejected and died | Rejected and died |
| . | P1 . | P2 . | P3 . |
|---|---|---|---|
| Immunodeficiency | |||
| Recurrent respiratory tract infections | ++ | + | ++ |
| Bronchiectasis | ++ | + | ++ |
| Herpes viral infection | ++ | + | + |
| Lymphoproliferation | |||
| Lymphadenopathy | + | + | + |
| Hepatosplenomegaly | + | + | + |
| Lymphoma | + | + | + |
| Autoimmunity | |||
| Autoimmune cytopenias | + | + | − |
| Autoantibodies | + | + | − |
| Laboratory values | |||
| Class-switched memory B cells | ↓ | ↓ | ↓ |
| FasL-mediated apoptosis | ↓ | ↓ | Normal |
| Soluble FasL | ↑ | ↑ | Normal |
| DNTs | ↑ | ↑/Normal | ↑ |
| Specific antibodies | Normal | ND | ↓ |
| Developmental delay | |||
| Moderate | + | + | + |
| Outcome of HSCT | |||
| Autologous T-cell reconstitution | + | + | + |
| Split mixed chimerism | Rejected and died | Rejected and died |
+, feature present; ++, major feature; −, feature absent; ↓, lower than normal; ↑, higher than normal; ND, not determined.